Cell Cycle/Checkpoint

The cell cycle is consisted of 4 main phases: Gap 1 (G1), DNA replication (S), Gap 2 (G2), and mitosis (M). There are “checkpoints” mechanism regulates the transition between these phases, at the G1/S boundary, in the S-phase and during G2/M phases. Cell can only pass through these checkpoints when signaling factors are activated and free of DNA damage. Important proteins that control cell cycle events and checkpoints are cullins, cyclins, cyclin-dependent kinases (Cdks), p53 and their inhibitors etc. Cdks family (Cdk2, Cdk3, Cdk4 and Cdk6) are Ser/Thr kinases that regulate cell cycle progression in association with cyclin binding partners (cyclin D, cyclin E and cyclin A) during all four phases. p53 halts the cell cycle if the DNA is damaged and allowing time for DNA repair to progress; it can also initiate apoptosis if DNA damage is too severe to be repaired.
-   B6076 MyoseverinSummary: microtubule-binding molecule B6076 MyoseverinSummary: microtubule-binding molecule
-   A4489 TC-A 2317 hydrochlorideTarget: Aurora KinasesSummary: Aurora kinase A inhibitor,potent and selective A4489 TC-A 2317 hydrochlorideTarget: Aurora KinasesSummary: Aurora kinase A inhibitor,potent and selective
-   A8501 PHA-848125Target: Cyclin-Dependent KinasesSummary: CDK inhibitor,potent and ATP-competitive A8501 PHA-848125Target: Cyclin-Dependent KinasesSummary: CDK inhibitor,potent and ATP-competitive
-   B5922 CevipabulinSummary: Anti-microtubule agent B5922 CevipabulinSummary: Anti-microtubule agent
-   A4488 Anacardic acidTarget: Histone Acetyltransferases (HATs)Summary: HAT inhibitor A4488 Anacardic acidTarget: Histone Acetyltransferases (HATs)Summary: HAT inhibitor
-   A8412 Dinaciclib (SCH727965)5 CitationTarget: Cyclin-Dependent KinasesSummary: Potent CDK inhibitor A8412 Dinaciclib (SCH727965)5 CitationTarget: Cyclin-Dependent KinasesSummary: Potent CDK inhibitor
-   B5870 ELR510444Summary: Novel microtubule disruptor B5870 ELR510444Summary: Novel microtubule disruptor
-   A8385 BMS265246Target: Cyclin-Dependent KinasesSummary: CDK1/2 inhibitor,potent and selective A8385 BMS265246Target: Cyclin-Dependent KinasesSummary: CDK1/2 inhibitor,potent and selective
-   B4892 TAI-1Target: Hec1Summary: Hec1 inhibitor, potent, first-in-class B4892 TAI-1Target: Hec1Summary: Hec1 inhibitor, potent, first-in-class
-   A4132 CCT137690Target: Aurora KinasesSummary: Aurora A/B/C inhibitor A4132 CCT137690Target: Aurora KinasesSummary: Aurora A/B/C inhibitor
